4//SEC Filing
Ndu Adora 4
Accession 0001415889-24-015089
CIK 0001070494other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 6:00 PM ET
Size
15.2 KB
Accession
0001415889-24-015089
Insider Transaction Report
Form 4
Ndu Adora
Director
Transactions
- Award
Director Stock Options (Right to Buy)
2024-05-29+15,959→ 15,959 totalExercise: $14.62Exp: 2034-05-28→ Common Stock (15,959 underlying) - Exercise/Conversion
Restricted Stock Units
2024-05-29−6,652→ 0 total→ Common Stock (6,652 underlying) - Award
Restricted Stock Units
2024-05-29+9,387→ 9,387 total→ Common Stock (9,387 underlying) - Exercise/Conversion
Common Stock
2024-05-29+6,652→ 11,033 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held.
- [F3]The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders.
- [F4]The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001865210
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 6:00 PM ET
- Size
- 15.2 KB